These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2073117)

  • 1. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
    Arika T; Yokoo M; Maeda T; Amemiya K; Yamaguchi H
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.
    Arika T; Yokoo M; Hase T; Maeda T; Amemiya K; Yamaguchi H
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2250-3. PubMed ID: 2073116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
    Syed TA; Maibach HI
    Expert Opin Pharmacother; 2000 Mar; 1(3):467-73. PubMed ID: 11249531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
    Arika T; Yokoo M; Yamaguchi H
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2523-5. PubMed ID: 1489197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Trichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs.
    Arika T; Hase T; Yokoo M
    Antimicrob Agents Chemother; 1993 Feb; 37(2):363-5. PubMed ID: 8452371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs.
    Itoyama T; Uchida K; Yamaguchi H; Fujita S
    J Antimicrob Chemother; 1997 Sep; 40(3):441-4. PubMed ID: 9338501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
    Uchida K; Kudoh M; Yamaguchi H
    Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butenafine.
    McNeely W; Spencer CM
    Drugs; 1998 Mar; 55(3):405-12; discussion 413. PubMed ID: 9530545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
    Tschen E; Elewski B; Gorsulowsky DC; Pariser DM
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
    Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
    Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butenafine: an update of its use in superficial mycoses.
    Gupta AK
    Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity of the new agent latoconazole in two tinea models.
    Ohmi T; Konaka S; Uchida M; Yamaguchi H
    Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG; Amar AK; Ravichandran G; Korde KM; Desai A
    J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
    Tanuma H; Doi M; Ohta Y; Abe M; Kume H; Mukai H; Katsuoka K
    Mycoses; 2001; 44(7-8):287-99. PubMed ID: 11714064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
    Reyes BA; Beutner KR; Cullen SI; Rosen T; Shupack JL; Weinstein MB
    Int J Dermatol; 1998 Jun; 37(6):450-3. PubMed ID: 9646136
    [No Abstract]   [Full Text] [Related]  

  • 18. Butenafine and superficial mycoses: current status.
    Singal A
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
    Tatsum Y; Yokoo M; Arika T; Yamaguchi H
    Microbiol Immunol; 2002; 46(7):425-32. PubMed ID: 12222928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Tatsumi Y; Yokoo M; Senda H; Kakehi K
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.